Amedisys Stock News

The following discussion and analysis provides information we believe is relevant to an assessment and understanding of our results of operations and financial condition for 2021, 2020 and 2019. For a discussion of a comparison of the years ended December 31, 2020 and December 31, 2019, please refer to "Management''s Discussion and Analysis of Financial… The post AMEDISYS INC – 10-K – MANAGEMENT''S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS appeared first on InsuranceNewsNet .

Amedisys (AMED) delivered earnings and revenue surprises of 0.86% and 0.73%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

BATON ROUGE, La. (AP) _ Amedisys Inc. (AMED) on Wednesday reported fourth-quarter earnings of $34 million. On a per-share basis, the Baton Rouge, Louisiana-based company said it had net income of $1.04. Earnings, adjusted for non-recurring costs, came to $1.18 per share. The results surpassed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $1.17 per share. The home health care and hospice services provider posted revenue of $559.3 million in the period, also surpassing Street forecasts. Seven analysts surveyed by Zacks expected $555.3 million. For the year, the company reported profit of $209.1 million, or $6.34 per share. Revenue was reported as $2.21 billion. Amedisys expects full-year earnings in the range of $5.23 to $5.45 per share, with revenue in the range of $2.33 billion to $2.37 billion. Amedisys shares have decreased 17% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $134.90, a decline of 52% in the last 12 months. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research.

BATON ROUGE, La., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2021.

BATON ROUGE, La., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2021.

Amedisys (AMED) delivered earnings and revenue surprises of 0.86% and 0.73%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Amedisys (NASDAQ:AMED) is scheduled to announce Q4 earnings results on Wednesday, Feb. 23, after market close.The consensus EPS estimate is $1.18 (-20.8% Y/Y)

Quest Diagnostics (DGX) delivered earnings and revenue surprises of -0.60% and 0.08%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Amedisys (AMED) to acquire Evolution Health, LLC, a division of Envision Healthcare, doing business as Guardian Healthcare, Gem City, and Care Connection of Cincinnati

BATON ROUGE, La., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and higher acuity care services, will report results for

BATON ROUGE, La., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and higher acuity care services, will report results for th

BATON ROUGE, La., Jan. 26, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, has recognized 37 employee

Amedisys (AMED) announced that Chairman and CEO Paul Kusserow will retire as CEO on April 15th, 2022. Upon his retirement as CEO, Mr

Dublin, Jan. 06, 2022 (GLOBE NEWSWIRE) -- The "The US At-Home Care Market: Size, Trends & Forecast with Impact of COVID-19 (2021-2025)" report has been added to ResearchAndMarkets.com''s offering.